Vitro Biopharma Receives Recognition from BioInformant

Vitro Biopharma Receives Recognition from BioInformant

Coronavirus disease (COVID-19) is an emerging global pandemic that is threatening the viability of healthcare systems worldwide. The virus responsible for the disease is also known as severe acute respiratory syndrome coronavirus 2 and abbreviated as SARS-CoV-2. The...

Vitro Biopharma First Quarter 2020 Financial Results of Operations

Golden, Colorado-March 26, 2020- Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma, announced its 1st quarter ended January 31st, 2020 financial results of operations. Vitro Diagnostics Inc. (“Vitro Biopharma”) is pleased to announce a record 1st comparative...
Investigating Stem Cell Therapy for the Coronavirus COVID-19 Pandemic

Investigating Stem Cell Therapy for the Coronavirus COVID-19 Pandemic

Golden, Colorado—March 17, 2020—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma reports on its therapy for the Coronavirus (COVID-19) pandemic.  Recent umbilical cord stem cell therapies in China to fight the Coronavirus are producing encouraging emergency...

Anti-Aging Effects of AlloRx Stem Cell Therapy & STEMulize

As we age, our cells get sick and die. When a cell dies, it creates a cascade of events, leading to inflammation and disease that can decrease lifespan. Many environmental factors accelerate aging such as stress, pollution, lifestyle, injuries, disease, and exposure...

Potential Stem Cell Therapy for Coronavirus Infection

Golden, Colorado—February 27, 2020—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma reports on a potential therapy of Coronavirus (COVID-19) infections by stem cell transplant.  While this therapy is not a method to eradicate or cure Coronavirus, there is...